120 related articles for article (PubMed ID: 8428622)
1. Isolation and biochemical characterization of the soluble and membrane forms of folate binding protein expressed in the ovarian carcinoma cell line IGROV1.
Tomassetti A; Coney LR; Canevari S; Miotti S; Facheris P; Zurawski VR; Colnaghi MI
FEBS Lett; 1993 Feb; 317(1-2):143-6. PubMed ID: 8428622
[TBL] [Abstract][Full Text] [Related]
2. The isolation and properties of multiple forms of folate binding protein in cultured KB cells.
Luhrs CA; Sadasivan E; da Costa M; Rothenberg SP
Arch Biochem Biophys; 1986 Oct; 250(1):94-105. PubMed ID: 3767384
[TBL] [Abstract][Full Text] [Related]
3. Immunoreactive folate-binding proteins from human saliva. Isolation and comparison of two distinct species.
Verma RS; Antony AC
Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):707-15. PubMed ID: 1417729
[TBL] [Abstract][Full Text] [Related]
4. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
5. Purification, properties, and immunological characterization of folate-binding proteins from human leukemia cells.
Sadasivan E; da Costa M; Rothenberg SP; Brink L
Biochim Biophys Acta; 1987 Jul; 925(1):36-47. PubMed ID: 3474029
[TBL] [Abstract][Full Text] [Related]
6. Gene transfection and expression of the ovarian carcinoma marker folate binding protein on NIH/3T3 cells increases cell growth in vitro and in vivo.
Bottero F; Tomassetti A; Canevari S; Miotti S; Ménard S; Colnaghi MI
Cancer Res; 1993 Dec; 53(23):5791-6. PubMed ID: 8242637
[TBL] [Abstract][Full Text] [Related]
7. Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro.
Sen S; Erba E; D'Incalci M; Bottero F; Canevari S; Tomassetti A
Br J Cancer; 1996 Feb; 73(4):525-30. PubMed ID: 8595169
[TBL] [Abstract][Full Text] [Related]
8. The conversion of the human membrane-associated folate binding protein (folate receptor) to the soluble folate binding protein by a membrane-associated metalloprotease.
Elwood PC; Deutsch JC; Kolhouse JF
J Biol Chem; 1991 Feb; 266(4):2346-53. PubMed ID: 1846624
[TBL] [Abstract][Full Text] [Related]
9. A human membrane-associated folate binding protein is anchored by a glycosyl-phosphatidylinositol tail.
Luhrs CA; Slomiany BL
J Biol Chem; 1989 Dec; 264(36):21446-9. PubMed ID: 2557328
[TBL] [Abstract][Full Text] [Related]
10. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19.
Mantovani LT; Miotti S; Ménard S; Canevari S; Raspagliesi F; Bottini C; Bottero F; Colnaghi MI
Eur J Cancer; 1994; 30A(3):363-9. PubMed ID: 8204360
[TBL] [Abstract][Full Text] [Related]
11. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous activity of two different mechanisms of folate transport in ovarian carcinoma cell lines.
Miotti S; Bagnoli M; Ottone F; Tomassetti A; Colnaghi MI; Canevari S
J Cell Biochem; 1997 Jun; 65(4):479-91. PubMed ID: 9178098
[TBL] [Abstract][Full Text] [Related]
13. High-affinity folate binding in human choroid plexus. Characterization of radioligand binding, immunoreactivity, molecular heterogeneity and hydrophobic domain of the binding protein.
Holm J; Hansen SI; Høier-Madsen M; Bostad L
Biochem J; 1991 Nov; 280 ( Pt 1)(Pt 1):267-71. PubMed ID: 1660267
[TBL] [Abstract][Full Text] [Related]
14. Development of a specific radioimmunoassay for the placental folate receptor and related high-affinity folate binding proteins in human tissues.
Antony AC; Verma RS; Kincade RS
Anal Biochem; 1987 Apr; 162(1):224-35. PubMed ID: 3037938
[TBL] [Abstract][Full Text] [Related]
15. A folate binding protein in ascitic fluid, serum and ovarian tissue of patients with ovarian adenocarcinoma immunoreacts with antibodies against human milk folate binding protein.
Holm J; Hansen SI; Høier-Madsen M; Helkjaer PE
Biosci Rep; 1998 Apr; 18(2):49-57. PubMed ID: 9743473
[TBL] [Abstract][Full Text] [Related]
16. Growth of ovarian-carcinoma cell lines at physiological folate concentration: effect on folate-binding protein expression in vitro and in vivo.
Miotti S; Facheris P; Tomassetti A; Bottero F; Bottini C; Ottone F; Colnaghi MI; Bunni MA; Priest DG; Canevari S
Int J Cancer; 1995 Nov; 63(3):395-401. PubMed ID: 7591238
[TBL] [Abstract][Full Text] [Related]
17. Characterization of multiple forms of folate-binding protein from human leukemia cells.
Sadasivan E; Rothenberg SP; da Costa M; Brink L
Biochim Biophys Acta; 1986 Jul; 882(3):311-21. PubMed ID: 3460637
[TBL] [Abstract][Full Text] [Related]
18. Hydrophobic erythrocyte folate binding proteins are converted to hydrophilic forms by trypsin in vitro.
Antony AC; Verma RS
Biochim Biophys Acta; 1989 Feb; 979(1):62-8. PubMed ID: 2917167
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Mg2+-dependent protease in human placenta which cleaves hydrophobic folate-binding proteins to hydrophilic forms.
Antony AC; Verma RS; Unune AR; LaRosa JA
J Biol Chem; 1989 Feb; 264(4):1911-4. PubMed ID: 2536692
[TBL] [Abstract][Full Text] [Related]
20. High-affinity folate receptor in human ovary, serous ovarian adenocarcinoma, and ascites: radioligand binding mechanism, molecular size, ionic properties, hydrophobic domain, and immunoreactivity.
Holm J; Hansen SI; Høier-Madsen M; Birn H; Helkjaer PE
Arch Biochem Biophys; 1999 Jun; 366(2):183-91. PubMed ID: 10356282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
